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esponsibility of InstAbstract Euphorbia factor L2, a lathyrane diterpenoid isolated from caper euphorbia seed (the seeds of
Euphorbia lathyris L.), has been traditionally applied to treat cancer. This article focuses on the cytotoxic
activity of Euphorbia factor L2 against lung carcinoma A549 cells and the mechanism by which apoptosis is
induced. We analyzed the cytotoxicity and related mechanism of Euphorbia factor L2 with an MTT assay, an
annexin V-FITC/PI test, a colorimetric assay, and immunoblotting. Euphorbia factor L2 showed potent
cytotoxicity to A549 cells. Euphorbia factor L2 led to an increase in reactive oxygen species (ROS) generation,
a loss of mitochondrial electrochemical potential, release of cytochrome c, activation of caspase-9 and caspase-
3, and cleavage of poly(ADP-ribose) polymerase, suggesting that Euphorbia factor L2 induced apoptosis
through a mitochondrial pathway. The cytotoxic activity of Euphorbia factor L2 in A549 cells and the related
mechanisms of apoptotic induction provide support for the further investigation of caper euphorbia seeds.
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Lung cancer is the leading cause of cancer-related mortality in the
world and non-small-cell lung cancer (NSCLC) is the most common
form of lung cancer1,2. Cancer chemotherapy has been regarded as
one of the most effective therapy and the development of new
anticancer agents is a promising strategy to treat cancer. Indeed, a
growing body of evidence suggests that the success of anticancer
chemotherapy depends on the discovery of novel anticancer agents3.
Traditional Chinese medicine provides a rich resource in the
search for novel anticancer agents, of which caper euphorbia seed
has been recorded for treating cancer4. The genus Euphorbia
(spurges, Euphorbiaceae) has received worldwide attention as its
exceptional diversity of growth forms and near-worldwide dis-
tribution5. It is the largest genus in the spurge family (Euphorbia-
ceae), containing more than 2000 species. The seeds of Euphorbia
lathyris L. (caper euphorbia seed) have been used medicinally for
the treatment of hydropsy, ascites, terminal schistosomiasis, and
snakebites6. What's more, the seeds of E. lathyris L. can be used
for cancer treatment7.
Multidrug resistance (MDR) is the major impediment to the
efﬁcient treatment of tumors. Previous studies revealed that
lathyrane diterpenes extracted from the seeds of E. lathyris L.,
Euphorbia factor L1–L11 (EFL1–11), have been considered as
promising P-glycoprotein (P-gp) modulators in MDR-mediated
resistance8,9. We have reported the isolation, identiﬁcation and
anticancer activity of EFL110. On that basis, we further isolated
EFL2 (Fig. 1A), and identiﬁed the structure using 1H and
13C NMR, DEPT and high resolution electrospray ionization mass
spectrometry (HR-EI-MS). The structure was also reported by
Appendino and co-workers11 from the same plant species. In this
study, we elucidated the mechanism of EFL2 cytotoxicity against
the lung cancer cell line A549. Our results reveal that EFL2 does
show potent cytotoxicity and induces apoptosis via a mitochon-
drial pathway in A549 cells.2. Materials and methods
2.1. Chemicals and reagents
EFL2 was isolated from the seeds of E. lathyris L. with a purity of
more than 98%. 3-(4,5-Dimethyl-2-thiazolyl)2,5-diphenyl-2H-tetra-
zolium bromide (MTT), 2ʹ,7ʹ-dichloroﬂuorescin diacetate (DCFH-
DA), 3,3ʹ-dihexyloxacarbocyanine iodide (DiOC6) were obtained from
Sigma Chemical Co. (USA). Primary antibodies were obtained as
follows: antibodies against GAPDH, anti-mouse IgG-HRP and anti-Figure 1 Structure of EFL2 and its cytotoxicity to A549 cells. (A) Ch
viability of A549 cells with log scale of concentration.rabbit IgG-HRP from KangChen Biotechnology Co. (Shanghai,
China), antibody against cytochrome c from Santa Cruz Biotechnol-
ogy Co. Colorimetric assay kits for caspase-9 and caspase-3 were
purchased from R&D systems (Minneapolis, MN, US). All tissue
culture supplies were products of Life Technologies. Other routine
laboratory reagents were obtained from commercial sources of
analytical or HPLC grade.
2.2. Cell lines and cell culture
Lung cancer A549 cells were maintained in RPMI 1640 medium
containing 100 U/mL penicillin, 100 μmol/L streptomycin, and
10% fetal bovine serum (FBS). Cells were cultured in a humidiﬁed
atmosphere incubator of 5% CO2 at 37 1C
12.
2.3. Cell viability assay
The effect of EFL2 on cell viability was detected by MTT assay.
Cells were harvested and transferred into 96-well plates at a
density of 5 104 cells/mL. After 24 h incubation, 10 μL EFL2
solution (0, 4.162, 6.243, 9.364, 14.05, 21.07, 31.60, 47.41, 71.11,
106.7, 160 and 240 μmol/L) was added to 96-well plates. After
68 h of treatment, 10 μL MTT (10 mmol/L stock solution in
saline) was added to each well and incubated in darkness for 4 h
at 37 1C. Subsequently, the supernatant was removed and 100 μL
anhydrous dimethyl sulfoxide was added into each well. Cell
viability was measured with a Model 550 Microplate reader (BIO-
RAD, USA) at 540 nm and 655 nm as reference ﬁlter. The growth-
inhibitory effect of EFL2 was expressed as IC50 estimated from the
concentration–response curve (Bliss's software). Cell survival was
calculated using the following formula13: Survival (%)¼ (Mean
experimental absorbance/Mean control absorbance) 100.
2.4. Annexin V-FITC/PI assay for apoptosis
Apoptosis was quantiﬁed by measuring surface exposure of
phosphatidylserine in apoptotic cells using an annexin V-FITC/
PI (propidium iodide) apoptosis detection kit (KeyGEN Biotech,
Nanjing, China) according to the manufacturer's protocol. Brieﬂy,
after A549 cells were treated with the indicated concentrations (40
and 80 μmol/L) of EFL2 for 48 h, the cells were collected and
washed twice with ice-cold phosphate-buffered saline (PBS). Then
5 105 cells were resuspended with 0.5 mL binding buffer
containing Annexin-V (1:50 according to the manufacturer's
instruction) and 40 ng/sample of PI for 30 min at 37 1C in the
dark. Subsequently, the cells were assayed by ﬂow cytometeremical structure of Euphorbia factor L2 (EFL2); (B) EFL2 inhibited
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ware (Becton Dickinson, USA). At least 10,000 cells were
analyzed for each sample. The apoptosis rate was calculated using
the following formula14: Apoptosis rate (%)¼ (Number of apop-
totic cells/Number of total cells observed) 100.
2.5. Measurement of ROS generation
The ﬂuorescence intensity of 2ʹ,7ʹ-dichloroﬂuorescein (DCF) is
proportional to the amount of reactive oxygen species (ROS)
produced by the cells. After exposure to the indicated concentra-
tions (40 and 80 μmol/L) of EFL2 for 24 h, 5  105 cells were
harvested, washed with PBS and incubated with DCFH-DA
(50 μmol/L in a ﬁnal concentration) at 37 1C for 20 min in the
dark. Then the cells were washed twice and resuspended in 1 mL
PBS. ROS generation was determined from 10,000 cells in each
sample by FACS (ﬂuorescence-activated cell sorting) with a
Caliber ﬂow cytometer (Beckman-coulter, Elite) at the excitation
wavelength of 488 nm and emission wavelength of 530 nm. The
data were analyzed by CellQuest software (Becton Dickinson,
USA) and expressed as median ﬂuorescence intensity (MFI)15.
2.6. Determination of mitochondrial membrane potential (ΔΨm)
A549 cells (5 105 cells/mL) were treated with EFL2 at the
indicated concentrations (40 and 80 μmol/L) for 24 h to determine
ΔΨm. The cells were collected, centrifuged at 600g for 5 min, and
washed with PBS. Thereafter cells were incubated with 40 nmol/L
DiOC6(3) at 37 1C for 20 min in the dark. Subsequently, the
stained cells were washed twice with chilled PBS prior to
suspension in 1 mL PBS, and then the amount of DiOC6(3)
retained by 10,000 cells per sample was analyzed by FASCanto
Flow Cytometer (Beckman Coulter Inc., USA) with the excitation
wavelength of 484 nm and emission wavelength of 501 nm. The
data obtained from ﬂow cytometry were analyzed with CellQuest
software (Becton Dickinson, USA) and expressed as MFI16.
2.7. Activities measurement of caspase-9 and caspase-3 by
colorimetric assay
The activities of caspase-9 and caspase-3 were measured with a
caspase colorimetric assay kit according to the manufacturer's
protocol. Brieﬂy, 1 106 cells were treated with 80 μmol/L EFL2
for 12, 24, 36 or 48 h. Subsequently, cells were collected, washed
with ice-cold PBS and lysed in lysis buffer. The lysates were assayed
for protease activity with the caspase-speciﬁc peptide conjugated with
the color reporter molecule p-nitroanaline. The chromophore p-
nitroanaline cleaved by caspases was quantiﬁed with the spectro-
photometer at a wavelength of 405 nm. The caspase enzymatic
activities in cell lysates were proportional to the color intensity11.
2.8. Western blot analysis of cytosolic cytochrome c, caspase-9,
caspase-3 and PARP
Expression of cytochrome c, caspase-9, caspase-3, and poly (ADP-
ribose) polymerase (PARP) was detected by Western blot analysis as
previously reported17. Approximately 3.5 106–4.0 106 cells/well
were seeded into culture dishes, incubated with 80 μmol/L EFL2 for 0,
12, 24, 48 h and then washed with ice-cold PBS.
For whole cell lysates, the pellet was lysed in 1 loading buffer
[50 mmol/L Tris–HCl (pH 6.8); 10% glycerol, v/v; 2% sodiumdodecylsulphate, w/v; 0.25% bromphenol blue, w/v; 0.1 mol/L
D,L-dithiothreitol (DTT)]. After treatment at 100 1C for 20 min, the
lysates were centrifuged and the supernatant was collected18.
For subcellular fractionation of cytosol, cells were harvested and
resuspended in a 5-fold volume of ice-cold cell extract buffer
[20 mmol/L HEPES-KOH (pH 7.5), 10 mmol/L KCl, 1.5 mmol/L
MgCl2, 1 mmol/L EDTA, 1 mmol/L EGTA, 1 mmol/L DTT,
250 mmol/L sucrose, 0.1 mmol/L phenylmethanesulfonyl ﬂuoride
(PMSF) and 0.02 mmol/L aprotinin] at 4 1C for 40 min. Then, the
ﬁnal supernatant after repeated centrifugation was collected and
dissolved in 5 loading buffer [250 mmol/L Tris–HCl (pH 6.8);
50% glycerol, v/v; 10% sodium dodecylsulphate, w/v; 1.25%
bromphenol blue, w/v; 0.5 mol/L DTT]. The samples were heated
at 100 1C for 15 min and subjected to Western blot analysis. Equal
amounts of protein were loaded onto 8%–12% sodium SDS-PAGE
and transferred to PVDF membranes (Millipore, USA) and the
membranes were incubated with speciﬁc primary antibodies. Proteins
were then visualized using HRP-conjugated secondary antibody and a
PhototopeTM-HRP detection kit (Cell Signaling, USA) on Kodak
medical X-ray processor (Kodak, USA). The cytochrome c protein
was detected by anti-cytochrome c antibody in a ratio of 1:100019,20.2.9. Statistical analysis
Results were analyzed by t-test or one-way ANOVA with SPSS
13.0 software (SPSS Inc., USA). Data are presented as mean7SD
of at least triplicate determinations. *Po0.05 and **Po0.01 were
considered signiﬁcant differences.3. Results
3.1. EFL2 exerted potent cytotoxicity against A549 cells
The cytotoxicity of EFL2 was measured by MTT assay. The IC50
of EFL2 was 36.8272.14 μmol/L for A549 cells (Fig. 1B),
suggesting that EFL2 exhibited potent cytotoxicity to A549 cells.3.2. EFL2-induced cell apoptosis in A549 cells
To explore whether the anti-tumor effect of EFL2 on A549 cells was
associated with apoptosis induction, the cells were treated with 40
and 80 μmol/L of EFL2 for 48 h and apoptosis was monitored by
ﬂow cytometry following annexin V and PI staining. The results
showed that apoptosis rates were 6.271.5%, 23.773.4%, 36.97
2.4% for control, 40 and 80 μmol/L EFL2, respectively (Fig. 2).3.3. EFL2-induced increase of intracellular ROS levels in A549
cells
It is well-known that an increase in intracellular ROS can lead to
apoptosis21. For this purpose, the generation of ROS was assessed
by a ﬂow cytometric method with DCFH-DA used as the
ﬂuorescent probe. After A549 cells were exposed to 40 and
80 μmol/L EFL2 for 24 h, the intracellular ROS levels were
266.23738.53% and 363.64740.26% of control, respectively
(Fig. 3). These results imply that EFL2 might cause the loss of
ΔΨm via ROS, which was subsequently shown by mitochondrial
membrane-potential assay.
Figure 2 EFL2-induced cell apoptosis in A549 cells. (A) A549 cells were treated with 0, 40 and 80 μmol/L of EFL2 for 48 h, apoptosis rates
were then detected by annexin V-FITC/PI double staining and ﬂow cytometer. D4 quadrant represented cells stained mainly by annexin-V (early
apoptotic cells) and D2 quadrant represented cells stained by both PI and annexin-V (late apoptotic). D1 quadrant represented cells stained mainly
by PI and viable cells negative for both annexin-V and PI appeared in the D3 quadrant. (B) The apoptosis rate was showed in the bar graph.
Figure 3 EFL2 increased ROS levels in A549 cells. (A) ROS
generation was increased in A549 cells; (B) ROS levels in A549 cells
were calculated as percentage of control.
Figure 4 EFL2 decreased ΔΨm in A549 cells. (A) The decrease of ΔΨm
level was observed in A549 cells; (B) ΔΨm level in A549 cells was
calculated as percentage of control.
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(ΔΨm) in A549 cells
Apoptosis is a complex and multifactorial process in which
mitochondria are involved. Generally, generation of ROS induced
by chemotherapeutical drugs would trigger mitochondrialpathway, leading to the loss of ΔΨm22. To investigate the
mechanisms of EFL2-induced apoptosis in A549 cells, the effects
of EFL2 on ΔΨm were determined by ﬂow cytometric analysis.
After A549 cells were treated with the indicated concentrations of
EFL2 for 24 h, the decrease in ΔΨm was observed in a
concentration-dependent manner (Fig. 4). After treatment, the
Figure 5 EFL2 activates the expression of cytochrome c in A549
cells. (A) Release of cytochrome c was discovered in A549 cells;
(B) activation of caspase-9 and caspase-3 were detected in A549 cells.
Figure 6 EFL2 activates the expression of caspase-9 and caspase-3,
and the cleavage of PARP in A549 cells in a time-dependent manner.
(A) Activation of caspase-9 and caspase-3, and the cleavage of PARP
were detected in A549 cells; (B) densitometric analysis of Western
blot results of (A). The molecular weight of activated (cleaved)
caspase-9, caspase-3 and cleaved PARP were 37, 17 and 89 kD,
respectively. GAPDH (36 kD) was used to conﬁrm equal protein
loading. Results were expressed as mean7SD of at least three
determinations.
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80 μmol/L EFL2, respectively. These data indicate that mitochon-
drial dysfunction is involved in the apoptosis induced by EFL2.
3.5. EFL2-induced release of cytochrome c
The increase in intracellular ROS and loss of ΔΨm have been
demonstrated to cause the release of cytochrome c. The release of
cytochrome c from mitochondria into the cytosol is a vital factor inthe mitochondrial pathway of apoptosis. In this regard, Western
blot analysis was used to determine the cytosolic levels of
cytochrome c. After A549 cells were treated with 80 μmol/L
EFL2 for indicated time, the release of cytochrome c was detected
in A549 cells (Fig. 5A).3.6. EFL2 activated the expression of caspase-9 and caspase-3,
and the cleavage of PARP
After release of cytochrome c, the caspase cascade would subse-
quently be activated. For this, the activation of caspase-9 and caspase-
3, and the cleavage of PARP were measured in A549 cells (Figs. 5B
and 6). After A549 cells were incubated with 80 mmol/L apicidin for
0, 12, 24, 48 h, cells were harvested and Western blot analysis was
used to determine relative levels of each protein. Densitometric ratios
of cleaved caspase-9 were 5.3370.72%, 26.0672.36%, 35.107
1.72% and 46.5172.83%, at the respective time-points. Densito-
metric ratios of cleaved caspase-3 were 5.5171.47%, 23.6871.15%,
35.9975.30% and 52.0473.29%, respectively. Densitometric ratios
of cleaved PARP were 2.0170.42%, 41.2474.11%, 59.7674.07%
and 77.5172.86%, respectively.
Taken together, EFL2 led to an increase in ROS generation, a
loss of mitochondrial potential, release of cytochrome c, activation
of caspase-9 and caspase-3, and the cleavage of PARP, which
suggests that EFL2-induced apoptosis of A549 cells through a
mitochondrial pathway.4. Discussion
Lung cancer continues to be the most common cause of cancer-
related mortality worldwide, killing more people than prostate, breast,
pancreas and colon cancers combined23. The trend in ﬁve-year
relative survival rates of lung cancer patients is only 15%. Although
some therapeutic advances have been achieved, such as chemother-
apy that provides useful palliation, therapies for advanced lung cancer
are far from satisfactory. A major problem in the treatment of lung
cancer is the MDR. Thus, novel approaches to enhance the
antitumorigenic effects of chemotherapeutic agents are required24.
Numerous natural cancer chemopreventive agents have already been
isolated and are being used for the treatment of cancers.
Recent research has revealed that herbal medicines and natural
products isolated from plants could provide additional strategies for
monotherapy or combination treatments. EFL2 was isolated from the
seeds of E. lathyris L. (Caper Euphorbia Seed). Our study showed that
it was able to inhibit the growth of human lung cancer A549 cells
potently with an IC50 value of 36.8272.14 μmol/L. Herein, we carried
out further investigations to elucidate the mechanisms involved.
As is well known, many chemotherapeutic drugs act by
inducing apoptosis. The apoptotic mechanism of cancer cells is
composed of both upstream regulators and downstream effector
components. The regulators can be divided into two major circuits.
One receives and processes extracellular death–inducing signals
which involve the Fas ligand/Fas receptor (the extrinsic apoptotic
program). The other senses and integrates a variety of signals of
intracellular origin (the intrinsic program). Each culminates in the
activation of caspases-8 and caspases-9, respectively. As to the
activation of protease, a cascade of proteolysis of effector caspases
directly responsible for the execution phase of apoptosis is
activated. In this way, the cancer cells are progressively disas-
sembled and then consumed both by neighboring cells and
Minting Lin et al.64phagocytic cells. Currently, the intrinsic apoptotic mechanism is
more widely implicated in cancer pathogenesis22,25.
Indeed, release of cytochrome c and activation of caspase-9 and
caspase-3 in time-dependent manner were observed in A549 cells
after exposure to EFL2 (Figs. 5 and 6). Caspase activity measured
by colorimetric assay (Fig. 5B) was essentially in agreement with
results obtained by Western blot (Fig. 6). What's more, the
cleavage of PARP was detected in our experiments (Fig. 6).
Taken together, EFL2 induced apoptosis of A549 via a mitochon-
drial pathway.
Generally, loss of mitochondrial membrane potential (ΔΨm) is
involved in the mitochondrial pathway. Consistently, ΔΨm of
A549 was decreased after treatment with EFL2 for 24 h showing
concentration-dependent pattern (Fig. 4). Furthermore, an increase
of ROS was noted (Fig. 3), which could cause the loss of ΔΨm.5. Conclusions
In summary, our study shows that the anticancer activity of EFL2
against lung cancer A549 cells involves mitochondrially-mediated
apoptosis, and provides evidence for the further investigation of
caper euphorbia seed.
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